The estimated Net Worth of Surbhi Sarna is at least $1.12 Milion dollars as of 2 January 2024. Ms. Sarna owns over 85 units of Penumbra Inc stock worth over $464,301 and over the last 5 years she sold PEN stock worth over $427,311. In addition, she makes $229,895 as Independent Director at Penumbra Inc.
Sign up
Ms. Sarna PEN stock SEC Form 4 insiders trading
Surbhi has made over 12 trades of the Penumbra Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 85 units of PEN stock worth $21,053 on 2 January 2024.
The largest trade she's ever made was selling 907 units of Penumbra Inc stock on 1 November 2021 worth over $252,200. On average, Surbhi trades about 89 units every 76 days since 2019. As of 2 January 2024 she still owns at least 2,295 units of Penumbra Inc stock.
You can see the complete history of Ms. Sarna stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Surbhi Sarna biography
Surbhi Sarna serves as Independent Director of the Company. Ms. Sarna is the CEO and founder of nVision Medical Corp (nVision), a healthcare company developing pioneering technology to enable early detection of ovarian cancer. Ms. Sarna founded nVision in 2011, with the intention of fulfilling an unmet clinical need. She has led the company from its inception and through its earliest days of product development, funding and initial clinical trials. In April 2018, nVision was acquired by Boston Scientific. Ms. Sarna now leads the efforts to commercialize the technology developed by nVision at Boston Scientific. Prior to her founding of nVision, Ms. Sarna held a variety of roles in healthcare, including roles at BioCardia and Abbott Vascular. Ms. Sarna received a B.A. from the University of California, Berkeley. The Board has nominated Ms. Sarna based on her valuable experience as Chief Executive Officer of a pioneering medical device company
What is the salary of Surbhi Sarna?
As the Independent Director of Penumbra Inc, the total compensation of Surbhi Sarna at Penumbra Inc is $229,895. There are 10 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of $2,556,370.
How old is Surbhi Sarna?
Surbhi Sarna is 34, she's been the Independent Director of Penumbra Inc since 2019. There are 17 older and no younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
What's Surbhi Sarna's mailing address?
Surbhi's mailing address filed with the SEC is ONE PENUMBRA PLACE, , ALAMEDA, CA, 94502.
Insiders trading at Penumbra Inc
Over the last 9 years, insiders at Penumbra Inc have traded over $197,637,326 worth of Penumbra Inc stock and bought 700 units worth $109,480 . The most active insiders traders include Adam Elsesser, Arani Bose a James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of $2,030,383. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth $159,614.
What does Penumbra Inc do?
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
What does Penumbra Inc's logo look like?
Complete history of Ms. Sarna stock trades at Penumbra Inc a Progenity
Penumbra Inc executives and stock owners
Penumbra Inc executives and other stock owners filed with the SEC include:
-
Johanna Roberts,
Executive Vice President, General Counsel, Secretary -
Maggie Yuen,
Chief Financial Officer -
Adam Elsesser,
Chairman of the Board, Chief Executive Officer -
Lynn Rothman,
Executive Vice President, Chief Business Officer -
Maggie S. Yuen,
Chief Financial Officer -
James Pray,
President, International -
Arani Bose,
Chief Innovator, Director -
Johanna Roberts,
Exec. VP, Gen. Counsel & Sec. -
Lambert Shiu,
Chief Accounting Officer -
Janet Leeds,
Independent Director -
Surbhi Sarna,
Independent Director -
Adam Elsesser,
Co-Founder, Chairman, Pres & CEO -
Harpreet Grewal,
Independent Director -
Bridget O'Rourke,
Independent Director -
Thomas Wilder,
Independent Director -
Don Kassing,
Presiding Independent Director -
Lambert Shiu,
Chief Accounting Officer -
Gita Barry,
Exec. VP & GM of Immersive Healthcare -
Ben Tompkins,
Exec. VP of Devel. -
Shruthi Narayan,
Director of Marketing - Vascular -
Dr. Arani Bose M.D.,
Co-Founder & Director -
Jee Hamlyn-Harris,
Investor Relations Officer -
Corey L. Teigen M.D.,
Chief Scientific Officer -
Ben Sorci,
Exec. VP of Operations -
Kevin James Sullivan,
Director -
Robert D. Evans,
EVP, Gen. Counsel & Secretary -
Daniel Donen Davis,
President, North America -
Sridhar Kosaraju,
President -
Walter Charles Wang,
Director